Ghost Tree Capital’s Pacira BioSciences PCRX Stock Holding History

Ghost Tree Capital’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-250,000	Closed	-$9.52M	–	55
2019 Q3	$9.52M	Buy	+250,000	New	+$9.98M	2.42%	17
2016 Q3	–	Sell	-120,000	Closed	-$4.05M	–	95
2016 Q2	$4.05M	Buy	+120,000	New	+$5.9M	1.17%	36
2016 Q1	–	Sell	-30,000	Closed	-$2.3M	–	61
2015 Q4	$2.3M	Sell	30,000 -50,000	-63%	-$2.83M	0.94%	37
2015 Q3	$3.29M	Buy	+80,000	New	+$4.9M	1.48%	24

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Ghost Tree Capital's PCRX Position: Q4 2019 in Review

Ghost Tree Capital sold out of Pacira BioSciences (PCRX) in Q4 2019, closing a stake of 250,000 shares — an estimated $9.52M sold.

Ghost Tree Capital first reported a position in PCRX in Q3 2015 and held it in 4 quarters. The position peaked at $9.52M in Q3 2019. 231 funds tracked by Wall St. Rank hold PCRX as of Q4 2019.

Ghost Tree Capital reported no remaining Pacira BioSciences position as of Q4 2019 after selling out during the quarter.
Ghost Tree Capital sold 250,000 Pacira BioSciences shares in Q4 2019, an estimated $9.52M.
Ghost Tree Capital first reported a position in Pacira BioSciences in Q3 2015 and held it in 4 quarters.
Ghost Tree Capital's Pacira BioSciences position peaked at $9.52M in Q3 2019.
231 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2019.

Based on Ghost Tree Capital's 13F filing for Q4 2019, filed 14 Feb 2020.